Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92.4M
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
9.17M
-
Shares change
-
-693K
-
Total reported value, excl. options
-
$115M
-
Value change
-
-$8.45M
-
Put/Call ratio
-
1.56
-
Number of buys
-
20
-
Number of sells
-
-19
-
Price
-
$12.50
Significant Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q3 2021
61 filings reported holding VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value as of Q3 2021.
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.17M shares
of 92.4M outstanding shares and own 9.92% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.61M shares), ORBIMED ADVISORS LLC (1.48M shares), KORNITZER CAPITAL MANAGEMENT INC /KS (728K shares), VANGUARD GROUP INC (692K shares), BlackRock Inc. (645K shares), Fosun International Ltd (282K shares), Altium Capital Management LP (256K shares), GEODE CAPITAL MANAGEMENT, LLC (238K shares), FMR LLC (237K shares), and STATE STREET CORP (228K shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.